With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
In this video, Sarah DiGeronimo, NP, and Sydney Smith, PharmD, both from Dana-Farber Cancer Institute, Boston, Massachusetts, discuss tips for the management of common side effects resulting from…
NEW YORK (Reuters Health) – Cervical preparation with prostaglandins before outpatient hysteroscopy does not reduce pain in women of reproductive age, researchers from UK report in the July…
NEW YORK (Reuters Health) – Postmenopausal women with ovarian cysts detected on ultrasound are not at increased risk of developing ovarian cancer or, for that matter, breast or…
NEW YORK (Reuters Health) – For removal of uterine contents during the second trimester, dilation and evacuation (D&E) appears to prompt fewer complications and may be more cost-effective…
NEW YORK (Reuters Health) – A new report concludes that expectant management of severe preeclampsia occurring before 34 weeks gestation is appropriate in selected cases. It can prolong…
NEW YORK (Reuters Health) – Over the past nearly 30 years, survivors of myocardial infarction have suffered an increasing rate of osteoporotic fractures, a new population-based cohort study…
NEW YORK (Reuters Health) – For women giving birth, a high-dose oxytocin regimen results in a shorter duration of labor without increasing the c-section rate or adversely affecting…
NEW YORK (Reuters Health) – In young women with breast cancer, temporary ovarian suppression by the gonadotropin-releasing hormone analogue triptorelin during chemotherapy reduces the occurrence of premature menopause,…
NEW YORK (Reuters Health) – In postmenopausal women with node-positive early breast cancer, substituting docetaxel for epirubicin for the last three cycles of chemotherapy may improve outcome without…
NEW YORK (Reuters Health) – Frenotomy in newborns with significant ankyloglossia rapidly improves breastfeeding scores and reduces maternal nipple pain, according to the results of a randomized trial…
NEW YORK (Reuters Health) – When used as adjuvant therapy in high-risk breast cancer or as primary treatment for metastatic breast cancer, high-dose chemotherapy (HDC) with autologous stem-cell…
